Raffael Nachbagauer

6.7k citations

69 papers · 3.5k indexed · 3 hit papers · h-index 32

Epidemiology top 0.5%
Immunology top 2%
Infectious Diseases top 1%
Molecular Biology
Radiology, Nuclear Medicine and Imaging top 5%

Co-authors: Florian Krammer Peter Palese Teddy John Wohlbold Adolfo Garcı́a-Sastre Ariana Hirsh Angela Choi Daniel Stadlbauer Randy A. Albrecht
Topics: Influenza Virus Research Studies (58 papers)Respiratory viral infections research (42 papers)Immune Cell Function and Interaction (15 papers)
Cited by: Epidemiology Infectious Diseases Immunology
Journals: Science Proceedings of the National Academy of Sciences Journal of Clinical Investigation
Partner nations: United States Austria United Kingdom

In The Last Decade

Raffael Nachbagauer

68 papers receiving 3.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Enhancement of Zika virus pathogenesis by preexisting antiflavivirus immunity

2017 387 citations Raffael Nachbagauer, Adolfo Garcı́a-Sastre et al. profile →
A Multi-Targeting, Nucleoside-Modified mRNA Influenza Virus Vaccine Provides Broad Protection in Mice

2020 207 citations Alec W. Freyn, Florian Krammer et al. profile →
A phase 3 randomized safety and immunogenicity trial of mRNA-1010 seasonal influenza vaccine in adults

2025 18 citations Angela Choi, Raffael Nachbagauer et al. Vaccine profile →

Peers

Countries citing papers authored by Raffael Nachbagauer

Since Specialization

Citations

This map shows the geographic impact of Raffael Nachbagauer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raffael Nachbagauer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raffael Nachbagauer more than expected).

Fields of papers citing papers by Raffael Nachbagauer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raffael Nachbagauer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raffael Nachbagauer. The network helps show where Raffael Nachbagauer may publish in the future.

Co-authorship network of co-authors of Raffael Nachbagauer

This figure shows the co-authorship network connecting the top 25 collaborators of Raffael Nachbagauer. A scholar is included among the top collaborators of Raffael Nachbagauer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raffael Nachbagauer. Raffael Nachbagauer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	AS03-adjuvanted H7N9 inactivated split virion vaccines induce cross-reactive and protective responses in ferrets 2021 ·npj Vaccines ·Daniel Stadlbauer,Leon de Waal,Édith Beaulieu,Shirin Strohmeier,Edwin J. B. Veldhuis Kroeze,Philippe Boutet,Albert D. M. E. Osterhaus,Florian Krammer,Bruce L. Innis,Raffael Nachbagauer,Koert J. Stittelaar,Corey P. Mallett	9
2	First exposure to the pandemic H1N1 virus induced broadly neutralizing antibodies targeting hemagglutinin head epitopes 2021 ·Science Translational Medicine ·Jenna J. Guthmiller,Julianna Han,Lei Li,Alec W. Freyn,Sean Liu,Olivia Stovicek,Christopher T. Stamper,Haley L. Dugan,Micah E. Tepora,Henry A. Utset,(unknown),(unknown),Siriruk Changrob,Nai‐Ying Zheng,Min Huang,Florian Krammer,Raffael Nachbagauer,Peter Palese,Andrew B. Ward,Patrick C. Wilson	42
3	Chimeric Hemagglutinin-Based Live-Attenuated Vaccines Confer Durable Protective Immunity against Influenza A Viruses in a Preclinical Ferret Model 2021 ·Vaccines ·Wen‐Chun Liu,Raffael Nachbagauer,Daniel Stadlbauer,Shirin Strohmeier,Alicia Solórzano,(unknown),Bruce L. Innis,Adolfo Garcı́a-Sastre,Peter Palese,Florian Krammer,Randy A. Albrecht	17
4	CD4+ follicular regulatory T cells optimize the influenza virus–specific B cell response 2020 ·The Journal of Experimental Medicine ·Yisi Lu,Ruoyi Jiang,Alec W. Freyn,Jiawei Wang,Shirin Strohmeier,Katlyn Lederer,Michela Locci,Hongyu Zhao,Davide Angeletti,Kevin C. O’Connor,Steven H. Kleinstein,Raffael Nachbagauer,Joe Craft	37
5	Activity of human serum antibodies in an influenza virus hemagglutinin stalk-based ADCC reporter assay correlates with activity in a CD107a degranulation assay 2020 ·Vaccine ·Veronika Chromikova,Jessica Tan,Sadaf Aslam,Arvind Rajabhathor,Maria C. Bermúdez‐González,Juan Ayllón,Viviana Simon,Adolfo Garcı́a-Sastre,Bruno Salaun,Raffael Nachbagauer,Florian Krammer	23
6	Enhancing Neuraminidase Immunogenicity of Influenza A Viruses by Rewiring RNA Packaging Signals 2020 ·Journal of Virology ·Allen Zheng,Weina Sun,Xiaoli Xiong,Alec W. Freyn,Julia Peukes,Shirin Strohmeier,Raffael Nachbagauer,John A. G. Briggs,Florian Krammer,Peter Palese	17
7	Pre-existing Antineuraminidase Antibodies Are Associated With Shortened Duration of Influenza A(H1N1)pdm Virus Shedding and Illness in Naturally Infected Adults 2019 ·Clinical Infectious Diseases ·Hannah E. Maier,Raffael Nachbagauer,Guillermina Kuan,Sophia Ng,Roger López,Nery Sánchez,Daniel Stadlbauer,Lionel Gresh,Amy Schiller,Arvind Rajabhathor,Sergio Ojeda,(unknown),Fatima Amanat,Ángel Balmaseda,Florian Krammer,Aubree Gordon	64
8	Development of Influenza B Universal Vaccine Candidates Using the “Mosaic” Hemagglutinin Approach 2019 ·Journal of Virology ·Weina Sun,Ericka Kirkpatrick,Megan E. Ermler,Raffael Nachbagauer,Felix Broecker,Florian Krammer,Peter Palese	56
9	Chimeric Hemagglutinin-Based Influenza Virus Vaccines Induce Protective Stalk-Specific Humoral Immunity and Cellular Responses in Mice 2019 ·ImmunoHorizons ·Angela Choi,(unknown),(unknown),Daniel Stadlbauer,Arvind Rajabhathor,(unknown),(unknown),Marie Van der Wielen,Peter Palese,Adolfo Garcı́a-Sastre,Bruce L. Innis,Florian Krammer,Michael Schotsaert,Corey P. Mallett,Raffael Nachbagauer	35
10	Novel correlates of protection against pandemic H1N1 influenza A virus infection 2019 ·Nature Medicine ·Sophia Ng,Raffael Nachbagauer,Ángel Balmaseda,Daniel Stadlbauer,Sergio Ojeda,Mayuri Patel,Arvind Rajabhathor,Roger López,(unknown),Nery Sánchez,Fatima Amanat,Lionel Gresh,Guillermina Kuan,Florian Krammer,Aubree Gordon	124
11	Pandemic influenza virus vaccines boost hemagglutinin stalk-specific antibody responses in primed adult and pediatric cohorts 2019 ·npj Vaccines ·Raffael Nachbagauer,Bruno Salaun,Daniel Stadlbauer,Mohammad Amin Behzadi,Damien Friel,Arvind Rajabhathor,Angela Choi,Randy A. Albrecht,Muriel Debois,Adolfo Garcı́a-Sastre,(unknown),Weina Sun,Peter Palese,Corey P. Mallett,Bruce L. Innis,Florian Krammer,Carine Claeys	18
12	Viral Fitness Landscapes in Diverse Host Species Reveal Multiple Evolutionary Lines for the NS1 Gene of Influenza A Viruses 2019 ·SSRN Electronic Journal ·Raquel Muñoz-Moreno,Carles Martínez‐Romero,Daniel Blanco-Melo,Christian V. Forst,Raffael Nachbagauer,Asiel A. Benitez,Ignacio Mena,Sadaf Aslam,Vinod Balasubramaniam,Ilseob Lee,Maryline Panis,Juan Ayllón,David Sachs,Man‐Seong Park,Florian Krammer,Benjamin R. tenOever,Adolfo Garcı́a-Sastre	1
13	Broadly Reactive Human Monoclonal Antibodies Elicited following Pandemic H1N1 Influenza Virus Exposure Protect Mice against Highly Pathogenic H5N1 Challenge 2018 ·Journal of Virology ·Raffael Nachbagauer,D.A. Shore,Hua Yang,Scott K. Johnson,Jon D. Gabbard,S. Mark Tompkins,Jens Wrammert,Patrick C. Wilson,James Stevens,Rafi Ahmed,Florian Krammer,(unknown)	24
14	A Universal Influenza Virus Vaccine Candidate Tested in a Pig Vaccination-Infection Model in the Presence of Maternal Antibodies 2018 ·Vaccines ·Sun-Young Sunwoo,Michael Schotsaert,Igor Morozov,A. Sally Davis,Yuhao Li,Jinhwa Lee,Chester D. McDowell,Philip Meade,Raffael Nachbagauer,Adolfo Garcı́a-Sastre,Wenjun Ma,Florian Krammer,Jüergen A. Richt	16
15	An immuno-assay to quantify influenza virus hemagglutinin with correctly folded stalk domains in vaccine preparations 2018 ·PLoS ONE ·Madhusudan Rajendran,Weina Sun,Phillip Comella,Raffael Nachbagauer,Teddy John Wohlbold,Fatima Amanat,Ericka Kirkpatrick,Peter Palese,Florian Krammer	24
16	Antigenic sites in influenza H1 hemagglutinin display species-specific immunodominance 2018 ·Journal of Clinical Investigation ·Sean Liu,Mohammad Amin Behzadi,Weina Sun,Alec W. Freyn,Wen‐Chun Liu,Felix Broecker,Randy A. Albrecht,Nicole M. Bouvier,Viviana Simon,Raffael Nachbagauer,Florian Krammer,Peter Palese	55
17	Analysis of Anti-Influenza Virus Neuraminidase Antibodies in Children, Adults, and the Elderly by ELISA and Enzyme Inhibition: Evidence for Original Antigenic Sin 2017 ·mBio ·Madhusudan Rajendran,Raffael Nachbagauer,Megan E. Ermler,(unknown),Fatima Amanat,Ruvim Izikson,Manon Cox,Peter Palese,Maryna C. Eichelberger,Florian Krammer	113
18	Vaccination with a Recombinant H7 Hemagglutinin-Based Influenza Virus Vaccine Induces Broadly Reactive Antibodies in Humans 2017 ·mSphere ·Daniel Stadlbauer,Arvind Rajabhathor,Fatima Amanat,Daniel H. Kaplan,(unknown),John J. Treanor,Ruvim Izikson,Manon Cox,Raffael Nachbagauer,Florian Krammer	34
19	Defining the antibody cross-reactome directed against the influenza virus surface glycoproteins 2017 ·Nature Immunology ·Raffael Nachbagauer,Angela Choi,Ariana Hirsh,Irina Margine,(unknown),Aldo Barrera,Marcela Ferrés,Randy A. Albrecht,Adolfo Garcı́a-Sastre,Nicole M. Bouvier,Kimihito Ito,Rafael Medina,Peter Palese,Florian Krammer	128
20	Influenza Virus Hemagglutinin Stalk-Specific Antibodies in Human Serum are a Surrogate Marker for In Vivo Protection in a Serum Transfer Mouse Challenge Model 2017 ·mBio ·Henning Jacobsen,Madhusudan Rajendran,Angela Choi,Haakon Sjursen,Karl A. Brokstad,Rebecca Jane Cox,Peter Palese,Florian Krammer,Raffael Nachbagauer	61

About Raffael Nachbagauer

Raffael Nachbagauer is a scholar working on Epidemiology, Immunology and Infectious Diseases, having authored 69 papers that have together received 3.5k indexed citations. Recurring topics across this work include Influenza Virus Research Studies (58 papers), Respiratory viral infections research (42 papers) and Immune Cell Function and Interaction (15 papers). The work is most often cited by research in Epidemiology (2.6k citations), Infectious Diseases (1.2k citations) and Immunology (1.2k citations). Raffael Nachbagauer has collaborated with scholars based in United States, Austria and United Kingdom. Frequent co-authors include Florian Krammer, Peter Palese, Teddy John Wohlbold, Adolfo Garcı́a-Sastre, Ariana Hirsh, Angela Choi, Daniel Stadlbauer, Randy A. Albrecht, Gene S. Tan and Rebecca Jane Cox. Their work appears in journals such as Science, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact